Ingevity (NGVT) Tops Q3 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Ingevity reports third quarter 2021 financial results
October 27, 2021 4:15 PM EDTHIGHLIGHTS: (comparisons versus prior year period)
Third quarter net sales of $376.8 million, up 13.6% Net loss of $4.2 million reflects an $85 million pre-tax expense for a litigation verdict, which had an after-tax impact on earnings of $1.64 per share Adjusted earnings of $64.4 million and adjusted earnings per share of $1.62 Adjusted EBITDA of $119.5 million and adjusted EBITDA margin of 31.7% Operating cash flow of $100.1 million drove free cash flow of $74.6 million Company updates full year 2021 guidance to sales between $1.320 billion and $1.360 billion and adjusted EBITDA between $405 million and $420 millionThe results and... More
